Atavistik Bio is a biotechnology company focused on discovering precision allosteric therapeutics by unlocking hidden functional pockets in target proteins. The company develops a proprietary discovery approach that identifies cryptic allosteric sites and rapidly advances small molecule therapeutics with the potential for high efficacy and tolerability. Its work targets high-need areas such as precision oncology and rare diseases, with plans to expand through partnerships to other therapeutic areas. Headquartered in the United States, Atavistik Bio emphasizes translating advanced science into transformative medicines for patients.
No recent news for this company.